May 16, 2007 09:30 ET

CDEX to Appear on MN1, May 17, 2007 at 12:30 EDT

TUCSON, AZ -- (MARKET WIRE) -- May 16, 2007 --CDEX's (OTCBB: CEXI) founding CEO and Chairman, Malcolm Philips, will be interviewed by MN1 on May 17, 2007, at 12:30 PM EDT to discuss the general structure of CDEX and it's technology, the Beta Cycle trials of CDEX's Methamphetamine Detection Unit, the Company's Medical product line -- ValiMed™ and CDEX's ongoing research programs. "We believe that our company is poised for growth in the marketplace and we are starting the process of introducing potential investors to this opportunity," said Mr. Philips.

About CDEX Inc.

CDEX Inc. is a technology development company with a current focus on developing and marketing products using chemical detection and validation technologies involving Enhanced Photoemission Spectroscopy. At present, CDEX is devoting its resources to two distinct areas: (i) identification of substances of concern (e.g., explosives and illegal drugs for homeland security); and (ii) validation of substances for anti-counterfeiting, brand protection and quality assurance (e.g., validation of prescription medication and detection of counterfeit or sub-par products for brand protection). ValiMed™ is one line of CDEX products for the healthcare market. CDEX has its headquarters and laboratory facilities in Tucson, Arizona. For more information, visit and


Market News First is an online, market news provider that brings investors current news on the market. Market News First is the only online, live IPTV web site that brings real market news to investors and features live interaction with companies from the Bulletin Board to NYSE.

Through daily, live interviews, we bring you up to date on all the established companies and inform the investors of the newest opportunities within the market. Market News First offers one-on-one interviews with the presidents and CFOs of companies to deliver answers to the questions that investors may ask and provides them insight into the companies' present condition and future plans.

Stay up to date with MN1 NewsWire "News You Can Trust" at

Any statements made in this press release which contain information that is not historical are essentially forward-looking. Forward-looking statements can be identified by the use of words such as "expects," "plans," "may," "anticipates," "believes," "should," "intends," "estimates," and other words of similar meaning. These statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, the ability of the Company to raise capital to finance the development of its products, the effectiveness, profitability and the marketability of those products, the ability of the Company to protect its proprietary information, the establishment of an efficient corporate operating structure as the Company grows and, other risks detailed from time-to-time in our filings with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statements.

Contact Information